focus -WSS

focus

author：fashion 2025-08-19 15:02:09 - browse：428

Sutter Health Palo Alto Medical Foundation facilities. health tech coverage from STAT — Adobe

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for example, how its former finance chief said the system would make an extra $200 million per year by making insurers contract with all of its hospitals instead of just a few. Or how its former CEO said, “Related to the health plans, we force them to pay us more.”

That evidence was indeed relevant, and the judge erred by not allowing it to be presented during the month-long trial that concluded in March 2022, a U.S. appeals court wrote in its ruling on Tuesday. The Ninth Circuit panel overturned Sutter’s win in the class-action case alleging that Sutter used its market power to drive up health care costs across the region by more than $400 million. Tuesday’s decision means the case will likely get a second trial.

“Effectively, the appellate court said the jury was tainted,” said Matthew Cantor, lead counsel for the plaintiffs. “So the jury’s verdict is discarded.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Listen: Wegovy in the brain & pivotal Alzheimer's data

WSS

AI can’t replace a physician’s gut feeling

CDC concerned about possible undetected monkeypox spread in U.K.

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

In early work, researchers turn to CRISPR to treat Alzheimer's

Medicare to cover more brain scans for Alzheimer’s patients

Why hospitals are withdrawing from US News rankings

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

knowledge

How to save PrEP access — and even expand it

Why drug prescriptions should include diagnoses

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Cloning humans is technically possible. It's curious no one has tried

Anesthesiologist group: stop taking Ozempic before surgery

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why are elite athletes different? Take a look at their microbes

The cancer drug shortage isn’t new — and neither are the solutions

Death of patient in Alzheimer’s trial raises question of possible risks

hotspot

FDA approves RSV monoclonal antibody for infants, toddlers

The strategy behind pharma's lawsuits over drug pricing reform

Sanders adds drug shortage policies to pandemic preparedness bill

Death of patient in Alzheimer’s trial raises question of possible risks

Sanders adds drug shortage policies to pandemic preparedness bill

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

knowledge

entertainment

focus

entertainment